National Health Investors Inc (NHI)

The Canada Pension Plan Investment Board has acquired a new position of $1.23 million in National Health Investors, Inc. (NYSE:NHI) during the second quarter, purchasing 16,100 shares. Other institutional investors have also adjusted their holdings in NHI, which is primarily owned by institutional investors and hedge funds (62.51%). Despite some recent target price reductions and a "strong sell" rating from Zacks, analysts maintain a "Moderate Buy" consensus rating with an average price target significantly above the current stock price, and company insiders recently purchased shares.

Legal & General Group Plc has acquired a new stake of 285,144 shares in National Health Investors, Inc. (NYSE:NHI), valued at approximately $21.7 million, representing a 0.58% ownership. The article highlights significant institutional ownership at 62.51% and recent insider buying by CEO D. Eric Mendelsohn and Director Robert A. McCabe Jr. NHI reported Q2 EPS of $1.19, maintained 2026 EPS guidance of $4.74-$4.79, and declared a $0.92 quarterly dividend, while analysts maintain a "Moderate Buy" rating with an average price target of $83.86.

National Health Investors, Inc. (NYSE:NHI) has finalized a Change in Control Severance Agreement with executive Christian Maingot, effective August 27, 2026. This agreement outlines severance benefits including cash payments, pro-rated bonuses, COBRA continuation for 18 months, and accelerated vesting of time-based equity awards, triggered by a qualifying termination linked to a change in control. The terms also include non-compete and non-solicitation clauses for 12 months post-termination if severance is paid, and an adjustment mechanism to potentially reduce payments to avoid Section 4999 excise tax if it benefits the executive.

Algert Global LLC increased its stake in National Health Investors, Inc. (NYSE:NHI) by 70.9% in the second quarter, purchasing an additional 103,285 shares. This raised their total holdings to 248,865 shares, valued at $18.98 million. Other institutional investors also adjusted their positions, and company insiders, including CEO D. Eric Mendelsohn and Director Robert A. Mccabe, Jr., acquired shares.

Morgan Stanley Institutional Investment Advisors LLC acquired 77,934 shares of National Health Investors (NHI) in the second quarter, valuing their new position at approximately $5.94 million. This investment represents 0.6% of Morgan Stanley's portfolio and 0.16% of NHI's outstanding shares. National Health Investors recently reported quarterly earnings of $1.19 per share on revenue of $121.32 million, reaffirmed its fiscal 2026 EPS guidance, and declared a quarterly dividend of $0.92 per share, equating to a 5.0% annualized yield.